Form 4: Quaker Chemical Corp Executive Exercises Options and Sells Shares

Sentiment:

SEC Form 4 Filing


A Form 4 filing reveals that Jeewat Bijlani, EVP and Chief Strategy Officer at Quaker Chemical Corp, exercised stock options and sold shares on November 22, 2024.

Summary

  • Jeewat Bijlani, an executive at Quaker Chemical Corp, exercised 645 stock options at a price of $154.92 per share on November 22, 2024.
  • Following the exercise of options, Mr. Bijlani sold 645 shares of common stock at a price of $165.9798 per share on the same day.
  • After these transactions, Mr. Bijlani directly owns 4,747 shares of common stock and indirectly owns 60 shares through a 401(k) plan.
  • The stock options exercised were part of a grant that vested in three annual installments.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing an executive's stock transactions, which is neither positive nor negative from an investment perspective.

Industry Context

This is a routine filing related to executive stock option exercises and sales, which is common in publicly traded companies. It provides transparency into insider transactions.

Comparison to Industry Standards

  • Executive stock option exercises and sales are a standard practice in publicly traded companies, and this transaction is consistent with typical compensation practices.
  • Form 4 filings are a common regulatory requirement for reporting insider transactions, ensuring transparency and preventing potential abuse of non-public information.
  • The vesting schedule of the options is typical for executive compensation packages, with vesting occurring over multiple years.

Stakeholder Impact

  • The transaction has a minor impact on shareholders as it involves a small number of shares compared to the total outstanding shares.
  • The transaction provides transparency to stakeholders regarding executive compensation and insider trading.

Key Dates

DateDescription
08/15/2019First vesting date of 807 shares of the stock option grant.
02/26/2020Second vesting date of 807 shares of the stock option grant.
02/26/2021Third vesting date of 807 shares of the stock option grant.
09/30/2024Date of the reporting person's Plan Statement used for indirect ownership information.
11/22/2024Date of the stock option exercise and share sale.
11/26/2024Date of the Form 4 filing.
02/26/2025Expiration date of the exercised stock options.

Keywords

Form 4, insider trading, stock options, share sale, Quaker Chemical Corp, KWR, executive compensation, equity securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.